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IN recent years development of tumours in different organs of mice following
administration of urethane (ethyl carbamate) has been reported by several
investigators. In addition to the carcinogenic action on lung tissue, known
since the early work of Nettleship and Henshaw (1943), urethane has recently
been found to have an initiating action in skin carcinogenesis (Salaman and Roe,
1953; Graffi et al., 1953) as well as the property of enhancing leukaemogenesis
by methylcholanthrene, oestrogenic hormones, X-rays, or viruses (Kawamoto
et at., 1958; Berenblum and Trainin, 1960, 1961; Chieco-Bianchi et al., 1963).
Moreover, the experimentation on newborn or infant mice (Pietra, Rappaport
and Shubik, 1961; Fiore-Donati et al., 1961; Liebelt, Yoshida and Gray, 1961;
Doell and Carnes, 1962; Klein, 1962) offered an opportunity to establish a
further broadening ofthe oncogenicproperties ofurethane, whichis now considered
as a multipotential carcinogen not only for mice (Tannenbaum and Silverstone,
1958) but also for hamsters (Toth, Tomatis and Shubik, 1961) and rats (Tannen-
baum et al., 1962).
Vascular lesions have frequently been found in the liver of mice treated with
urethane at adult age (Roe and Salaman, 1954; Berenblum and Haran, 1955;
Roe 1957; Tannenbaum and Silverstone, 1958; Kawamoto et al., 1961 ; Toth,
Della Porta and Shubik, 1961; Deringer, 1962) in contrast to the rare occurrence
of hepatomas. On the other hand, when urethane was administered to newborn
or infant mice a high incidence of hepatomas was observed (Liebelt et al., 1961;
Klein, 1962). Heston, Vlahakis and Deringer (1960) reported an increased
incidence ofhepatomas in male C3Hfmice injected with a single dose of urethane
at 2-3 months of age. However, as the same authors pointed out, the very high
incidence ofhepatomas in untreated controls makes these results open to question.
It was therefore considered of interest to investigate the role of age in the
neoplastic response of hepatic cells to urethane in mice of a strain having a very
low incidence of spontaneous hepatomas. Furthermore, an additional study was
designed to elucidate whether in skin carcinogenesis also the age ofrecipient mice
at the time of initiation by urethane would influence the development of skin
tumours following the promoting action of croton oil.
MATERIAL AND METHODS
Mice.-Swiss mice ofboth sexes, bred at random in this laboratory since 1959,
were used. They were housed in wooden cages, in a temperature-controlled
room at 21-23° C. and provided with ARSAL mouse diet and water ad libitum.AGE AND SU'SCEPTIBILITY TO CARCINOGENESIS
Chemical substances.-Urethane (ethyl carbamate) was obtained from Carlo
Erba S.p.A., Milano. Croton oil (Boots' Pure Drug Co.) was obtained through the
courtesy of Dr. F. Zajdela, Institut du Radium, Paris. Paraffin oil was obtained
from E. Merck, Darmstadt.
EXPERIMENTAL PROCEDURES
Liver carcinogenesis
Experiment 1. Newborn mice were injected subcutaneously in the inter-
scapular region within the first 24 hours of life with a single dose of 2 mg. of
urethane in 0 05 ml. of distilled water. This dose was approximately equivalent
to 1 mg./g. of body weight since the weight of new born Swiss mice of our colony
ranges, in litters of 6-7 units, from 1.8 to 2.1 g. Accordingly, only litters of this
size were used throughout the experiments. A certain number of animals died
spontaneously within the first months from leukaemia, other tumours, or non-
neoplastic diseases. The survivors were killed in groups at serial intervals, i.e.
180, 240, 300, 360, 420, 480, days of age. Some mice that died spontaneously
between the days of sacrifice were assigned to the nearest experimental group
according to the time of death.
Experiment 2. Three groups ofanimals were used. They received at the age of
5, 20 and 40 days, respectively, a single dose of 1 mg./g. ofbody weight ofurethane
in distilled water. The urethane was injected into the subcutaneous tissues of
the flank. All the survivors were killed at the end of the experiments, that is
420 days after urethane injection. For both the experiments 450 untreated
Swiss mice that died spontaneously between 360 and 720 days of age, served as
controls.
All animals were completely autopsied and tumours in the liver and other
organs were recorded. Tumours and all lesions suspected of being neoplastic
were excised and fixed in Bouin's fluid for histological examination. Haematoxy-
lin and eosin was used as routine staining method.
Skin carcinogenesis
Experiment 3.-Newborn animals, less than 24 hours old, received a single
injection of urethane as in Experiment 1. Forty days later, applications of
croton oil were begun and then continued twice a week for 10 months. The
experiment ended twelve months after the beginning of croton oil treatment,
when all the survivors were killed. 0-05 ml. of a 5 per cent v/v solution of croton
oil in paraffin oil was applied to an area of about 1.5 x 2 cm. of the anterior
region of the back, previously clipped with electric clippers. In the course of
the experiment the painted area was kept shorn with scissors. Two other groups
of animals receiving urethane alone or croton oil alone, respectively, served as
controls.
Experiment 4.-Animals of 40 days of age received in the subcutaneous tissues
of the flank a single injection of 1 mg./g. of body weight of urethane in distilled
water Forty days later treatment with croton oil was begun and then continued
as in Experiment 3 for 10 months. The survivors were killed twelve months after
the beginning of croton oil treatment. A control group was given urethane alone
as a single injection of 1 mg./g. of body weight at the age of 40 days. The group
ofExperiment 3 treated with croton oil alone served as control for this experiment
also, in spite of a difference of 40 days of age at time of first painting.
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Experiment 5.-Thirty mg. ofurethane was given by stomach tube in 0.25 ml.
of distilled water to each of a group of lactating mothers on the 1st, 3rd and 5th
day afterparturition. Thelitters werereducedwhennecessary to a standardnum-
ber of 6 animals, in order to uniform the suckling. The young were weaned at
30 days of age and divided into two groups. One group received no other treat-
ment and served as control; the other group was painted with croton oil starting
at 40 days of age and then continued as in Experiment 3. For this experiment
also the group of Experiment 3 treated with croton oil alone served as control.
712 mice aged 6 to 18 months served as untreated controls for all the experimental
groups.
Mice were inspected once a week and skin tumours of 1 mm. and over were
recorded. Tumours which regressed within two weeks from first appearance
were not considered in the finalresults. In untreated controls skin tumours were
detected only at autopsy; therefore no data are available on the age at which
tumours appeared and on the percentage of tumour regression. Skin tumours
and selected organs were taken for histological examination. They were fixed
routinely in Bouin's fluid and stained with haematoxylin and eosin. In some
cases frozen and formalin fixed sections of papillomas were used for ultra-violet
examination and toluidine blue staining.
RESULTS
Liver carcinogenesis
The data concerning the incidence of hepatomas developing in mice, injected
with urethane at birth and then killed at different intervals, are summarized in
Table I.
TABLE I.-Incidence of Hepatoma8 in Male and Female Swiss Mice Injected at
Birth With a Single Dose of 1 mg./g. of Body Weight of Urethane, and Killed
at Different Ages
Number
Age at Number ofmice
death ofmice bearing Incidence
Group (days) Sex examined tumours (per cent)
1 . 180 . M . 20 . 1 . 5
F . 20 . 0 . 0
2 . 240 M . 17 . 2 . 12
F . 12 . 0 . 0
3 . 300 . M . 18 . 5 . 28
F . 16 . 0 . 0
4 . 360 . M 20 . 11 . 55
F . 23 . 0 . 0
5* . 420 . M . 15 . 13 . 87
F . 22 . 2 . 9
6 . 480 . M . 23 . 17 . 74
F . 25 . 2 . 8
Untreated . 360-720 . M . 227 . 10 . 4-4
controls . . F . 222 . 4 . 1.8
* This group is the same as group 1 reported in Table II.
It is evident that a high incidence ofhepatomas developed only in males. The
number of mice bearing hepatomas increased gradually with the age of animals
whenkilled, theslight decrease oftumourincidence observedinthelastgroup beingAGE AND SUSCEPTIBILITY TO CARCINOGENESIS 675
statistically not significant. Very few hepatomas were found in females, and only
in groups killed at 420 and 480 days, with an incidence which was respectively
slightly significant (X2 - 443 0-01 < P < 0.05) or not significant in comparison
with the incidence of spontaneous hepatomas among untreated females.
TABLE II.-Incidence of Hepatomas in Male and Female Swiss Mice Receiving a
Single Dose of 1 mg./g. of Body Weight of Urethane at Different Ages, and
Killed at 420 days After Treatment
Number
Age at Number of mice
treatment ofmice bearing Incidence
Group (days) Sex examined tumours (per cent)
it . 1 . M . 15 . 13 . 87
F . 22 . 2 . 9
2 5 . M . 13 . 9 . 70
F . 11 . 2 . 18
3 . 20 M . 13 . 1 . 8
F . 16 . 0 . 0
4 . 40 . M . 11 . 0 . 0
F . 9 . 0 . 0
tThis group is the same as group 5 reported in Table I.
Table II provides data on the comparative incidence of hepatomas in mice
receiving urethane at different ages. It can be seen that a high incidence
developed in males only among those animals which were injected as newborn
or at 5 days of age. Few hepatomas occurred in females and only in groups
injected at birth or at 5 days of age.
In addition to hepatomas, vascular lesions were occasionally noted in the
livers ofanimals injected with urethane at birth. They were found in one female
and one male killed at 240 days, in one male killed at 360 days, in one female and
one male at 420 days, and in three females at 480 days. In animals of Experi-
ment 2, only one female receiving urethane at 5 days of age had hepatic vascular
lesions. In no case were these lesions associated with hepatomas.
Hepatomas appeared almost invariably as multiple tumours of various size,
elevated above the surface of liver, with many serpiginous, congested vessels
running under the hepatic capsule. On section they were usually paler than
normal hepatic tissue, but occasionally signs ofhaemorrhage or necrosis were seen.
Histologically, all hepatomas were of well differentiated liver-cell type, consisting
of hepatic cords with alternate sinusoids. Very few mitotic figures were seen.
UJsually many dilated vessels were contained within the neoplastic tissue. Meta-
stasis were never found in regional lymph nodes or elsewhere.
Vascular lesions appeared grossly as small areas of dark-reddish colour.
They had the histological appearance oflarge blood cysts or more often of caver-
nous haemangiomas showing a low degree of angioblastic proliferation. No
signs ofmalignancy were found.
The mice exposed to urethane developed neoplasms of other types in addition
to liver tumours. Almost all mice had multiple pulmonary adenomas. A
significant number ofanimals injected at birth or at 5 days ofage died within the
first six months with malignant lymphomas. A few mammary tumours were
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tumours of uterus, ovary, and forestomach were also observed, mainly in mice
injected as newborns or at 5 days of age.
Skin carcinogenesis
In Table III are summarized data on development of skin tumours in mice
given urethane as initiator at newborn or adult age, as well as through the
maternal milk, and then treated with croton oil as promoter.
TABLE III.-Development of Skin Papillomas in Swiss Mice Receiving Urethane at Birth, at 40
Days of Age, or Through Maternal Milk, Followed by Repeated Applications of Croton Oil
Average Average Incidence
Route of Age at Tumour latent number of tumour
administra- treatment bearing/ Incidence periodt tumours regression
Group Treatment tion* (days) survivors (per cent) (days) per mouse (per cent)
1 Urethane s.c. 1
plus 26/59 44 104 0 88 53
croton oil p.c. 40
2 Urethane s.c. 1 5/58 9 231 0410 16
3 Croton oil p.c. 40 3/63 5 223 0-08 20
4 Urethane s.c.
plus 40 8/41 19 5 108 0 24 40
croton oil p.c.
5 Urethane s.c. 40 2/24 3 221,376 0 04 0
6 Urethane maternal 0-6
plus milk 8/44 18 122 0-22 50
croton oil p.c. 40
7 Urethane maternal 0-6 0/75 - - -
milk
8 Untreated - 30,'712 4-2 not 0 04 riot
controls determined determined
* s.c. = subcutaneous; p.c. = percutaneous.
t Calculated at appearance of first tumours, from the beginning of croton oil paintings for groups 1, 3, 4, and
6; from urethane injection for groups 2 and 5.
Higher incidence of skin papillomas was observed in mice receiving urethane
at birth followed by croton oil treatment than in mice given urethane at 40 days
of age and then similarly treated with croton oil (%2 6-50 0.01 < P < 0.05).
The mean latent period, however, was practically the same. The tumour inci-
dence in mice receiving urethane through the maternal milk followed by croton
oil paintings was also significantly higher than in the control group treated with
croton oil alone (x2 = 5.09 0-01 < P < 0.05), although remarkably smaller
than among mice given urethane at birth followed by croton oil. In all the three
groups receiving urethane plus croton oil no sex difference was observed.
Among mice of control groups papillomas developed in one female and four
males of 58 mice given urethane alone at birth, in two females of 64 mice given
urethane alone at 40 days of age, and in two females and one male of 63 mice
receiving croton oil alone. No skin tumours developed in mice given urethane
alone via the maternal milk.
Among untreated mice 8 of 280 females and 22 of432 males, autopsied between
180 and 550 days of age, had spontaneous skin papillomas.AGE AND SUSCEPTIBILITY TO CARCINOGENESIS
In all groups receiving combined treatment the mean latent period at appea-
rance of the first papillomas was shorter than in control groups treated with
urethane alone or with croton oil alone. A large number of papillomas regressed
in all groups, the incidence of regressing tumours being about 50 per cent of the
total number in groups receiving combined treatment. Malignant transformation
of papillomas occurred in only two animals of the group injected with urethane
at birth and then painted with croton oil.
Nearly all tumours developing in animals treated with croton oil, either follow-
ing urethane administration or given alone, arose in the painted area. In control
animals receiving urethane alone at birth, 4 of the 5 animals bearing papillomas
had tumours localized in the posterior part of the back. In the 30 untreated
mice with papillomas, no preferential localization of tumours was noted.
Grossly, the tumours appeared as sessile or pedunculated papillomas, or more
rarely as rounded projections having the characteristics of keratoacanthomas.
Histologically, true papillomas consisted of a branched core of connective tissue
covered by hyperplastic squamous epithelium. Keratoacanthomas were com-
posed of masses of squamous epithelium, deeply invaginated in the dermis, with
a central keratinous cavity. In the fibrous bulk of the tumours there was a
considerable number of mast cells, especially at the neck of the growth. The
accumulated mast cells were of small size and loaded with relatively few, slightly
metachromatic granules. The majority of these mast cells exhibited under
ultra-violet light a strong golden-yellow primary fluorescence. This pattern was
found in all papillomas examined, whether spontaneous or experimentally pro-
duced, and had a close resemblance to the mast cell reaction reported in mouse
skin carcinogenesis by 9,10-dimethyl-1,2-benzanthracene (Fiore-Donati et al.,
1962a).
In this experiment also male mice receiving urethane at birth with or without
subsequent treatment with croton oil, developed a high incidence of hepatomas.
A certain number of hepatomas (18 per cent) was also found in mice treated with
urethane through the maternal milk. In addition, other types of tumours were
observed, as reported in the experiments on liver carcinogenesis.
DISCUSSION
The results of the present study confirm previous observations on the higher
susceptibility of newborn or very young versus adult mice to the oncogenic
activity of urethane. As regards the development of hepatomas, the data
reported clearly indicate that the age at time of treatment is a crucial factor in
conditioning the liability of liver tissue to undergo neoplastic transformation
under the oncogenic stimulus of urethane. Thus, while a high incidence of
hepatomas was found in mice injected at birth or at 5 days of age (87 and 70
per cent, respectively), few or no hepatomas were detected in animals injected
at 20 and 40 days. It is noteworthy that a very similar close relationship between
age of recipient mice and tumour incidence has previously been observed in
experiments on leukaemia induction by urethane (Fiore-Donati et al., 1962b).
On the other hand, while little or no difference has been reported between sexes
in lung adenomas (De Benedictis et al., 1962) or leukaemia (Toth, Della Porta
and Shubik, 1961 ; Fiore-Donati et al., 1962b) occurring after administration of
urethane, the development of hepatomas seems to depend largely on the sex of
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recipient animals. In our experiments with Swiss mice as well as in those of
Liebelt, Yoshida and Gray (1961) with C3Hf mice and in those of Klein (1962)
with B6AF1/J hybrid mice, males proved far more susceptible than females to
hepatoma induction by this chemical. Although similar sex difference has been
observed in mice and in rats treated with different carcinogens (Klein, 1959;
Morris and Firminger, 1956; Mulay and O'Gara, 1962), the influence of sex hor-
mones on hepatocarcinogenesis is still not clearly defined.
It is of interest to note that no relationship of sex with vascular lesions in the
liver or other organs has been observed by us or others. It must be pointed out,
however, that in the present study as well as in the experiment of Klein (1962)
very few liver angiomas were found, in contrast to the findings of other authors
(Roe and Salaman, 1954; Berenblum and Haran, 1955; Roe, 1957; Tannen-
baum and Silverstone, 1958; Kawamoto et al., 1961; Toth, Della Porta and
Shubik, 1961; Deringer, 1962). No explanation for these divergent results can
be offered at present, although dosage of urethane, age and strain of animals,
and route of administration could be of some importance in this regard. It must
be emphasized also that the induction ofhepatomas by urethane requlres a rather
long period of latency, as shown by the occurrence of the highest incidence of
tumours in mice killed 420 and 480 days after treatment. This might explain
why few or no hepatomas were found in other experiments, in which animals were
not kept under observation long enough for these tumours to develop.
The initiating action ofurethane on skin carcinogenesis, whether appliedlocally
(Salaman and Roe, 1953; Graffi et al., 1953) or systemically (Haran and Beren-
blum, 1956), is now firmly established. In our experiments the yield of skin
papillomas in mice treated once with urethane at 40 days of age and then repea-
tedly with croton oil, is somewhat less than the tumour incidence observed by
others in adult Swiss mice similarly treated (Haran and Berenblum, 1956;
Berenblum and Haran-Ghera, 1957). Since the sample of croton oil used in
the present study was obtained from Dr. Zajdela, who in turn had received it
some time before from Professor I. Berenblum, it is possible that the time elapsed
had caused a certain loss ofpotency ofthe substance. Nevertheless, even at this
low level of efficacy, the age at which urethane was administered as initiator
seems to represent an important factor in the development of tumours. Mice
given urethane when newborn followed by croton oil developed skin papillomas
with an incidence significantly higher (44 per cent) than mice submitted to the
initiating action of urethane at the age of 40 days (19.5 per cent). However,
mice receiving urethane through maternal milk also had a relatively low incidence
of papillomas (18 per cent). Although the exact dose of urethane cannot ob-
viously be determined, it is conceivable that by this route of administration only
a small amount of the drug reached the skin. Therefore, the fact that all these
three groups receiving the same croton oil treatment, had different tumour
yields, but almost the same latency, is consistent with the original hypothesis of
Berenblum and Shubik (1947) that on the basis of the two-stage theory of skin
carcinogenesis, tumour incidence is a function ofinitiating action while the latent
period is a function ofpromoting action.
The occurrence of skin papillomas as well as hepatomas in mice suckled by
mothers treated with urethane confirms previous results on lung tumour induction
showing that urethane administered to lactating mothers can be transferred to
the offspring by way of the milk (De Benedictis et al., 1962).AGE AND SUSCEPTIBILITY TO CARCINOGENESIS 679
In the control group treated with urethrane alone, 5 of 58 mice developed skin
papillomas after a meanlatent period of231 days. Fourofthese 5 mice were males.
The difference of tumour incidence in this group (9 per cent) with the incidence
among untreated control mice (4.2 per cent) was statistically not significant.
However, as mentioned above, in mice used in experiments on liver carcinogenesis
injected with urethane at birth, the incidence of skin papillomas reached 12 per
cent. In this group also the majority of mice bearing papillomas were males
(21 out of 24). By a re-examination ofall records it was found that in both these
two groups treated with urethane alone when newborn, most of the papillomas
had arisen on the skin of the lower back, hind limbs, and perianal region, where
signs of ulceration or scarring from fighting were seen. Although no definite
conclusions can be drawn from this evidence, it is noteworthy that Toth, Della
Porta and Shubik (1961) also reported the occurrence of a few papillomas on the
skin of the lower back in male Swiss mice given large amounts of urethane as
adults in the drinking water. It may well be that suchpapillomas have developed
as result of traumatic injury acting as promoter on the epidermis already " ini-
tiated " by urethane. Urethane administered to newborns in a single dose, or
to adults in such a way as to keep constant its concentration in the body for a
prolonged time, i.e. in the drinking water, might presumably exert a better
initiating action than under different experimental conditions.
SUMMARY
Previous observations on the higher susceptibility ofnewborn or very young as
compared with adult mice to the oncogenic activity of urethane were confirmed.
High incidence of hepatomas developed after a long latent period only in
males injected at birth or at 5 days of age with a single dose of urethane. The
number of animals bearing hepatomas increased progressively with time after
treatment, reaching the maximum (87 per cent) in the group killed at 420 days
after urethane injection.
In experiments on skin carcinogenesis, animals given urethane at birth and
then painted repeatedly with croton oil developed skin papillomas with an inci-
dence significantly higher than animals receiving urethane as adults followed by
croton oil paintings.
Hepatoma induction as well as skin initiation by urethane administered
through thematernal milk confirmprevious results on lung carcinogenesis, showing
that urethane given to lactating mothers can be transferred to the offspring by
way ofthe milk.
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